Levels of cathepsins in acute myocardial infarction

Indian Heart Journal

Volumn 64, Issue 3, 2012, Pages 290-294

  Shalia, Kavita K ^a   Mashru, Manoj R ^a   Shah, Vinod K ^a   Soneji, Surendra L ^a   Payannavar, Satchidanand ^a  

^a Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

Author keywords

Acute myocardial infarction; Cathepsins; Cystatin C; Stable angina

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CYSTATIN C; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOWN REGULATION; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MALE; PROTEIN BLOOD LEVEL; SMOKING; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

EID: 84870878007     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0019-4832(12)60089-3     Document Type: Article

References (18)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
2. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remod- eling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-62.
3. Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-7.
4. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1359-66.
5. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-83.
6. Jormsjö S, Wuttge DM, Sirsjö A, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002; 161: 939-45.
7. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathespins B, L, and S by human monocyte-derived macrophages. Proc Natl Acad Sci USA 1995; 92: 3849-53.
8. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105: 2766-71.
9. Lutgens E, Lutgens SP, Faber BC, et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibro- sis but accelerates macrophage foam cell formation. Circulation 2006; 113: 98-107.
10. Li W, Konmark L, Jonasson L, Forssell C, Yuan XM. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 2009; 202: 92-102.
11. Liu J, Sukhova GK, Yang JT, et al. Cathepsin L expression and regu- lation in human abdominal aortic aneurysm, atherosclerosis and vascular cells. Atherosclerosis 2006; 184: 302-11.
12. Liu J, Ma L, Yang J, et al. Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 2006; 186: 411-9.
13. Vivanco F, Martín-Ventura JL, Duran MC, et al. Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 2005; 4: 1181-91.
14. Shah VK, Shalia KK, Mashru MR, et al. Role of matrix metallopro- teinases in coronary artery disease. Indian Heart J 2009; 61: 44-50.
15. Fukuda D, Shimada K, Tanaka A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myo- cardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006; 97: 175-80.
16. Sarnak MJ, Katz R, Fried LF, et al. Cystain C and aging success. Arch Intern Med 2008; 168: 147-53.
17. Wang J, Sim AS, Wang XL, et al. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis 2008; 197: 853-9.
18. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005; 51: 321-7.